TABLE 3.
Severe hypoglycemia (SH) rate per 100 patient years (95%CI) adjusted for gender, age group and duration of diabetes and incidence rate ratio (IRR) (95%CI) by treatment regimen, registry, and HbA1c category
PATIENTS TREATED BY CSII | |||||
---|---|---|---|---|---|
HbA1c (%) category | <7% | 7% to <8% | 8% to <9% | ≥9% | |
DPV | No. cases | 2,512 | 3,676 | 2,647 | 2,197 |
SH rate | 2.6 (1.9–3.6) | 2.3 (1.8–3.0) | 2.8 (2.1–3.8) | 2.3 (1.5–3.6) | |
IRR | 1.15 (0.77–1.73) | 1.00 | 1.22 (0.82–1.83) | 1.01 (0.61–1.68) | |
T1DX | No. cases | 143 | 624 | 897 | 1,214 |
SH rate | 6.8 (4.0–11.8) | 5.2 (3.9–6.9) | 4.9 (3.2–7.7) | 8.4 (6.1–11.4) | |
IRR | 1.31 (0.71–2.42) | 1.00 | 0.95 (0.64–1.42) | 1.61 (1.06–2.44)* | |
WACDD | No. cases | 45 | 211 | 157 | 149 |
SH rate | 6.9 (2.0–2.4) | 3.5 (1.4–8.4) | 3.6 (1.0–13.0) | 5.6 (0.1–28.3) | |
IRR | 1.99 (0.43–9.13) | 1.00 | 1.03 (0.22–4.88) | 1.61 (0.25–10.24) | |
PATIENTS TREATED BY INJECTIONS | |||||
HbA1c (%) category | <7% | 7% to <8% | 8% to <9% | ≥9% | |
DPV | No. cases | 1,823 | 3,058 | 1,830 | 1,044 |
SH rate | 3.8 (3.0–4.9) | 3.9 (3.2–4.7) | 5.1 (4.1–6.3) | 2.5 (1.9–3.4) | |
IRR | 0.99 (0.73–1.38) | 1.00 | 1.32 (0.99–1.76) | 0.66 (0.46–0.93)† | |
T1DX | No. cases | 331 | 1,502 | 1,466 | 925 |
SH rate | 6.1 (2.6–14.4) | 4.9 (3.9–6.9) | 10.1 (7.4–13.7) | 8.9 (6.8–11.6) | |
IRR | 1.23 (0.47–3.25) | 1.00 | 2.05 (1.20–3.51) ‡ | 1.80 (1.08–3.02)* | |
WACDD | No. cases | 45 | 146 | 74 | 38 |
SH rate | 2.8 (0.6–14.3) | 0.7 (3.7–12.1) | 6.8 (3.4–13.6) | 1.0 (5.0–19.3) | |
IRR | 0.42 (0.08–2.30) | 1.00 | 1.02 (0.42–2.50) | 1.47 (0.59–3.68) |
Abbreviations: DPV, Diabetes Patienten Verlaufsdokumenation; HbA1c, glycated hemoglobin; T1DX, Type 1 Diabetes Exchange; WACDD, Western Australian Children Diabetes Database.
P = .03,
P = .02,
P = .009.